Published: 2023-11-10 Cross-Border Collaboration Facilitates Flagship Biotech Investments Joint News Release Date: November 5th, 2023 Leading Taiwanese and Japanese biotech venture capitals ally. Diamond Biofund from Taiwan and DCI Partners Co., Ltd. (wholly owned by Daiwa Securities Group, referred to as DCI Partners) from Japan jointly announced that the two parties have established a cross-border...Read More

Published: 2023-10-31 Taiwan’s first Taiwan Stock Exchange (TWSE)-listed venture capital firm, Diamond Biofund, has proudly announced a substantial investment of US$4 million in SYNCELL Inc. This investment is intended to facilitate the pilot production of cutting-edge Spatial Biology instruments in Taiwan, preparing for global market entry. Founded by Dr. Chung-Chi Liao, SYNCELL Inc., a spin-off...Read More

Published: 2023-09-19 Diamond Biofund Takes Off: Biotech in Acceleration Diamond Biofund (TWSE: 6901) joined the Taiwan Stock Exchange Mainboard on September 19, 2023 as the first public evergreen venture capital dedicated to biotech investments. This milestone event in Taiwan’s capital market aims to inspire more evergreen venture capital funds to invest in emerging and innovative...Read More